
2.91 Delayed Data As of Jun 02 | ![]() Today’s Change | 1.60 Today|||52-Week Range 3.79 | +53.16% Year-to-Date |
The 10 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 6.00, with a high estimate of 12.00 and a low estimate of 2.70. The median estimate represents a +106.19% increase from the last price of 2.91.
The current consensus among 11 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.